155 related articles for article (PubMed ID: 2957702)
1. Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet.
Hedin G; Weiland O; Ljunggren K; Strömberg A; Nordenfelt E; Hansson BG; Oberg B
Prog Clin Biol Res; 1987; 234():309-20. PubMed ID: 2957702
[No Abstract] [Full Text] [Related]
2. Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response?
Hansson BG; Riesbeck K; Nordenfelt E; Weiland O
Prog Clin Biol Res; 1991; 364():421-7. PubMed ID: 1826956
[TBL] [Abstract][Full Text] [Related]
3. Foscarnet in fulminant hepatitis B.
Price JS; France AJ; Moaven LD; Welsby PD
Lancet; 1986 Nov; 2(8518):1273. PubMed ID: 2878146
[No Abstract] [Full Text] [Related]
4. Screening of antiviral drugs for treatment of hepatitis B.
Tsiquaye KN; Collins P; Zuckerman AJ
J Hepatol; 1986; 3 Suppl 2():S45-8. PubMed ID: 2955032
[No Abstract] [Full Text] [Related]
5. Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
Ulbricht A; Färber I; Wutzler P
Acta Virol; 1985 Dec; 29(6):493-8. PubMed ID: 2869661
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
Al-Samarai A; Kinghorn G; Potter C
Chemioterapia; 1987 Jun; 6(2 Suppl):665-6. PubMed ID: 2855616
[No Abstract] [Full Text] [Related]
7. [Treatment of cytomegalovirus infections in immunosuppressed patients].
Michon C; Girard PM; Ngovan P; Simonpoli AM; Le Hoang P
Ann Med Interne (Paris); 1988; 139(7):511-5. PubMed ID: 2854380
[No Abstract] [Full Text] [Related]
8. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J
J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921
[No Abstract] [Full Text] [Related]
9. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks.
Sherker AH; Hirota K; Omata M; Okuda K
Gastroenterology; 1986 Oct; 91(4):818-24. PubMed ID: 2943628
[TBL] [Abstract][Full Text] [Related]
10. Foscarnet for cytomegalovirus infections.
Ringdén O; Wilczek H; Lönnqvist B; Gahrton G; Wahren B; Lernestedt JO
Lancet; 1985 Jun; 1(8444):1503-4. PubMed ID: 2861426
[No Abstract] [Full Text] [Related]
11. Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.
Ahlmén J; Wijnween AC; Brynger H; Lycke E
Scand J Urol Nephrol Suppl; 1985; 92():41-4. PubMed ID: 3008316
[TBL] [Abstract][Full Text] [Related]
12. [Importance of Foscarnet in the treatment of cytomegalovirus pneumopathy in a patient with acquired immunodeficiency syndrome].
Brochard L; Salmeron S; Herve P; Petitpretz P; Boissonnas A; Simonneau G; Duroux P
Presse Med; 1986 Nov; 15(40):2022-3. PubMed ID: 3025830
[No Abstract] [Full Text] [Related]
13. Foscarnet.
Lancet; 1985 Sep; 2(8456):648-9. PubMed ID: 2863637
[No Abstract] [Full Text] [Related]
14. The potential of phosphonoformate for the treatment of herpex simplex labialis.
Oxford J
J Antimicrob Chemother; 1980 Nov; 6(6):694-5. PubMed ID: 6449499
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of foscarnet for recurrent orolabial herpes: a multicentre randomized double-blind study.
Lawee D; Rosenthal D; Aoki FY; Portnoy J
CMAJ; 1988 Feb; 138(4):329-33. PubMed ID: 2962712
[TBL] [Abstract][Full Text] [Related]
16. Declining levels of HIV P24 antigen in serum during treatment with foscarnet.
Bergdahl S; Sönnerborg A; Larsson A; Strannegard O
Lancet; 1988 May; 1(8593):1052. PubMed ID: 2896890
[No Abstract] [Full Text] [Related]
17. Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.
Ganly PS; Arthur C; Goldman JM; Schulenburg WE
Postgrad Med J; 1988 May; 64(751):389-91. PubMed ID: 2849092
[TBL] [Abstract][Full Text] [Related]
18. [Current status of treatment of chronic hepatitis B].
Cital López JL; Figueroa Damián R; Fuentes Allen JL
Rev Gastroenterol Mex; 1990; 55(4):243-8. PubMed ID: 1708914
[No Abstract] [Full Text] [Related]
19. [Liver, biliary tracts and human immunodeficiency virus infection. 1:q liver, HIV and hepatitis B, C and D viruses].
Vuitton DA; Chossegros P; Bresson-Hadni S; Delfraissy JF; Kirn A; Marcellin P; Pol S; Saint-Paul MC
Gastroenterol Clin Biol; 1996; 20(3):269-80. PubMed ID: 8763066
[No Abstract] [Full Text] [Related]
20. Clinicopathological study of fulminant hepatitis: coinfection with hepatitis B virus and delta agent.
Krajden S; Bishai F; Huang SN; Ronald A; Harris F; Kempston J; Anderson J; Keston S
CMAJ; 1986 Dec; 135(11):1282-5. PubMed ID: 3536053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
